Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.0043 | 1 |
mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |